Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study

Inclusion Criteria:

• Subjects attending emergency room due to potential HIV exposition of either sex:

• Aged 18 years or more.

• Who have been exposed to non-occupational HIV and who meet the prerequisites for thecurrent recommendations to begin prophylaxis post-exposition with threeantiretroviral drugs.

• Who after being fully informed, give their written consent to participate in thestudy and undergo the tests and examinations required.

• Individuals able to do follow up correctly.

Exclusion Criteria:

• Pregnant women or nursing mothers or women trying to conceive during the studyperiod.

• Patients in whom it is known or suspected that the source case has a resistance toone of the drugs from the study treatment regimens.

• Treatment with drugs that are contraindicated in the study or products that are inthe investigational phase.

• Allergic reactions or intolerance to the compounds of the study treatment regiments